loadpatents
name:-0.79459476470947
name:-0.37038993835449
name:-0.030313968658447
Mascola; John Patent Filings

Mascola; John

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mascola; John.The latest application filed is for "neutralizing antibodies to hiv-1 gp41 and their use".

Company Profile
19.25.40
  • Mascola; John - Bethesda MD
  • Mascola; John - Rockville MD
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Anti-coronavirus antibodies and methods of use
Grant 11,447,541 - Westendorf , et al. September 20, 2
2022-09-20
Anti-coronavirus antibodies and methods of use
Grant 11,370,828 - Westendorf , et al. June 28, 2
2022-06-28
Neutralizing Antibodies To Hiv-1 Gp41 And Their Use
App 20220098286 - Kwong; Peter ;   et al.
2022-03-31
Prefusion Rsv F Proteins And Their Use
App 20220064222 - Kwong; Peter ;   et al.
2022-03-03
Neutralizing antibodies to HIV-1 GP41 and their use
Grant 11,236,152 - Kwong , et al. February 1, 2
2022-02-01
Prefusion Piv F Immunogens And Their Use
App 20220024987 - Zhang; Baoshan ;   et al.
2022-01-27
Anti-Coronavirus Antibodies and Methods of Use
App 20210388066 - WESTENDORF; Kathryn ;   et al.
2021-12-16
Monoclonal Anitbody For Spike Protein Of Middle East Respiratory Syndrome Coronavirus And Use Thereof
App 20210355193 - Lee; Hansaem ;   et al.
2021-11-18
Hiv-1 Env Fusion Peptide Nanoparticle Carrier Conjugates And Their Use
App 20210353740 - Kwong; Peter ;   et al.
2021-11-18
Substitutions-modified prefusion RSV F proteins and their use
Grant 11,174,292 - Kwong , et al. November 16, 2
2021-11-16
Neutralizing Antibodies To Gp120 And Their Use
App 20210324053 - Connors; Mark ;   et al.
2021-10-21
Recombinant HIV-1 envelope proteins and their use
Grant 11,136,356 - Kwong , et al. October 5, 2
2021-10-05
Nipah Virus Immunogens And Their Use
App 20210299242 - Graham; Barney ;   et al.
2021-09-30
Anti-Coronavirus Antibodies and Methods of Use
App 20210292393 - WESTENDORF; Kathryn ;   et al.
2021-09-23
Prefusion PIV F immunogens and their use
Grant 11,078,239 - Zhang , et al. August 3, 2
2021-08-03
Self-assembling Insect Ferritin Nanoparticles
App 20210198324 - Kwong; Peter ;   et al.
2021-07-01
Recombinant Hiv-1 Envelope Proteins And Their Use
App 20210188921 - Kwong; Peter ;   et al.
2021-06-24
Self-assembling insect ferritin nanoparticles for display of co-assembled trimeric antigens
Grant 10,961,283 - Kwong , et al. March 30, 2
2021-03-30
Neutralizing Antibodies To Hiv-1 Env And Their Use
App 20210079070 - Lusso; Paolo ;   et al.
2021-03-18
Broadly neutralizing HIV-1 antibodies that bind to the CD4-binding site of the envelope protein
Grant 10,815,295 - Kwong , et al. October 27, 2
2020-10-27
Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use
Grant 10,759,846 - Graham , et al. Sep
2020-09-01
Hiv-1 Env Fusion Peptide Immunogens And Their Use
App 20200230229 - Kwong; Peter ;   et al.
2020-07-23
Neutralizing Antibodies To Gp120 And Their Use
App 20200231658 - Connors; Mark ;   et al.
2020-07-23
Broadly Neutralizing Monoclonal Antibodies Against HIV-1 V1V2 Env Region
App 20200199204 - Schramm; Chaim Aryeh ;   et al.
2020-06-25
Neutralizing antibodies to gp120 and their use
Grant 10,562,960 - Connors , et al. Feb
2020-02-18
Prefusion Piv F Immunogens And Their Use
App 20200048311 - Zhang; Baoshan ;   et al.
2020-02-13
Broadly neutralizing monoclonal antibodies against HIV-1 V1V2 Env region
Grant 10,519,222 - Schramm , et al. Dec
2019-12-31
Recombinant Hiv-1 Envelope Proteins And Their Use
App 20190389915 - Kwong; Peter ;   et al.
2019-12-26
Zika Viral Antigen Constructs
App 20190345205 - DOWD; Kimberly ;   et al.
2019-11-14
Self-assembling Insect Ferritin Nanoparticles For Display Of Co-assembled Trimeric Antigens
App 20190330279 - Kwong; Peter ;   et al.
2019-10-31
Recombinant HIV-1 envelope proteins and their use
Grant 10,400,015 - Kwong , et al. Sep
2019-09-03
Middle East Respiratory Syndrome Coronavirus Immunogens, Antibodies, And Their Use
App 20190256579 - Graham; Barney ;   et al.
2019-08-22
Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use
Grant 10,301,377 - Graham , et al.
2019-05-28
Substitutions-modified Prefusion Rsv F Proteins And Their Use
App 20190112340 - Kwong; Peter ;   et al.
2019-04-18
Neutralizing Antibodies To Hiv-1 Gp41 And Their Use
App 20190077849 - Kwong; Peter ;   et al.
2019-03-14
Broadly Neutralizing Hiv-1 Antibodies That Bind To The Cd4-binding Site Of The Envelope Protein
App 20190016786 - Kwong; Peter D. ;   et al.
2019-01-17
Neutralizing Antibodies To Gp120 And Their Use
App 20180298083 - Connors; Mark ;   et al.
2018-10-18
Middle East Respiratory Syndrome Coronavirus Immunogens, Antibodies, And Their Use
App 20180244756 - Graham; Barney ;   et al.
2018-08-30
Neutralizing GP41 antibodies and their use
Grant 10,047,147 - Connors , et al. August 14, 2
2018-08-14
Neutralizing antibodies to HIV-1 and their use
Grant 10,035,845 - Mascola , et al. July 31, 2
2018-07-31
Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein
Grant 10,035,844 - Kwong , et al. July 31, 2
2018-07-31
Antibody evolution immunogens
Grant 10,004,800 - Haynes , et al. June 26, 2
2018-06-26
Neutralizing Antibodies To Hiv-1 And Their Use
App 20170369558 - Mascola; John ;   et al.
2017-12-28
HIV-1 broadly neutralizing antibodies
Grant 9,796,774 - Mascola , et al. October 24, 2
2017-10-24
Neutralizing Antibodies To Hiv-1 And Their Use
App 20170267748 - Kwong; Peter D. ;   et al.
2017-09-21
Neutralizing antibodies to HIV-1 and their use
Grant 9,738,703 - Mascola , et al. August 22, 2
2017-08-22
Recombinant Hiv-1 Envelope Proteins And Their Use
App 20170233441 - Kwong; Peter ;   et al.
2017-08-17
Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein
Grant 9,695,230 - Kwong , et al. July 4, 2
2017-07-04
Broadly Neutralizing Monoclonal Antibodies Against HIV-1 V1V2 Env Region
App 20160362479 - Schramm; Chaim Aryeh ;   et al.
2016-12-15
Novel Hiv -1 Broadly Neutralizing Antibodies
App 20160289305 - Mascola; John ;   et al.
2016-10-06
HIV-1 broadly neutralizing antibodies
Grant 9,382,311 - Mascola , et al. July 5, 2
2016-07-05
Neutralizing Antibodies To Hiv-1 And Their Use
App 20160009789 - Mascola; John ;   et al.
2016-01-14
Antibody Evolution Immunogens
App 20150366961 - HAYNES; Barton F. ;   et al.
2015-12-24
Immunogens Based On An Hiv-1 V1v2 Site-of-vulnerability
App 20140348865 - Kwong; Peter ;   et al.
2014-11-27
Neutralizing Gp41 Antibodies And Their Use
App 20140342407 - Connors; Mark ;   et al.
2014-11-20
Neutralizing Antibodies To Hiv-1 And Their Use
App 20140322163 - Kwong; Peter D. ;   et al.
2014-10-30
Conformationally stabilized HIV envelope immunogens
Grant 8,715,686 - Kwong , et al. May 6, 2
2014-05-06
Novel Hiv -1 Broadly Neutralizing Antibodies
App 20130251726 - Mascola; John ;   et al.
2013-09-26
Conformationally Stabilized Hiv Envelope Immunogens
App 20120328641 - Kwong; Peter ;   et al.
2012-12-27
Conformationally stabilized HIV envelope immunogens
Grant 8,268,323 - Kwong , et al. September 18, 2
2012-09-18
Conformationally Stabilized Hiv Envelope Immunogens
App 20120034255 - Kwong; Peter ;   et al.
2012-02-09
Conformationally stabilized HIV envelope immunogens and triggering HIV-I envelope to reveal cryptic V3-loop epitopes
Grant 8,044,185 - Kwong , et al. October 25, 2
2011-10-25
Conformationally Stabilized Hiv Envelope Immunogens And Triggering Hiv-1 Envelope To Reveal Cryptic V3-loop Epitopes
App 20090191235 - Kwong; Peter ;   et al.
2009-07-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed